Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab

Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease

(2012) Gerd R Burmester et al.   ANNALS OF THE RHEUMATIC DISEASES

Mortality rates in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: Drug-specific comparisons in the Swedish Biologics Register

(2012) Julia F. Simard et al.   ARTHRITIS AND RHEUMATISM

Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?

(2011) A. Strangfeld et al.   ANNALS OF THE RHEUMATIC DISEASES

Treating rheumatoid arthritis to target: recommendations of an international task force

(2010) J. S. Smolen et al.   ANNALS OF THE RHEUMATIC DISEASES

No evidence of association between anti-tumor necrosis factor treatment and mortality in patients with rheumatoid arthritis: Results from the British Society for Rheumatology Biologics Register

(2010) Mark Lunt et al.   ARTHRITIS AND RHEUMATISM

Associations of disease activity and treatments with mortality in men with rheumatoid arthritis: results from the VARA registry

(2010) T. R. Mikuls et al.   RHEUMATOLOGY

Tumor necrosis factor-α blockade, cardiovascular outcomes, and survival in rheumatoid arthritis

(2010) Ziyad Al-Aly et al.   Translational Research

Different Methods of Balancing Covariates Leading to Different Effect Estimates in the Presence of Effect Modification

(2009) M. Lunt et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Risk of Herpes Zoster in Patients With Rheumatoid Arthritis Treated With Anti–TNF-α Agents

(2009) Anja Strangfeld   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events

(2008) J P Leombruno et al.   ANNALS OF THE RHEUMATIC DISEASES